The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - ARIAD
Stock and Other Ownership Interests - ARIAD
 
Honoraria - ARIAD; AstraZeneca; Novartis; Pfizer; Roche
Consulting or Advisory Role - ARIAD; AstraZeneca; Novartis; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Roche
Research Funding - ARIAD; AstraZeneca; Clovis Oncology; Daiichi Sankyo; Ignyta; Novartis; Pfizer; Roche
Brigatinib (BRG) in patients (pts) with crizotinib (CRZ)-refractory ALK+ non-small cell lung cancer (NSCLC) and brain metastases in the pivotal randomized phase 2 ALTA trial.
 
Sai-Hong Ignatius Ou
No Relationships to Disclose
 
Marcello Tiseo
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Novartis; Otsuka; Pierre Fabre
Research Funding - ARIAD
 
D. Ross Camidge
Honoraria - ARIAD
Research Funding - ARIAD
 
Myung-Ju Ahn
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis
 
Rudolf M. Huber
Honoraria - ARIAD; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer; Roche
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; Lilly; Novartis; Roche
Research Funding - Pierre Fabre
 
Maximilian J. Hochmair
No Relationships to Disclose
 
Sang-We Kim
No Relationships to Disclose
 
Howard Jack West
Consulting or Advisory Role - ARIAD; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Guardant Health; Merck; Novartis
Speakers' Bureau - ARIAD; Genentech/Roche
 
Karen L. Reckamp
Consulting or Advisory Role - Amgen; ARIAD; Astellas Pharma; Boehringer Ingelheim; Euclises; Nektar
Research Funding - Adaptimmune (Inst); ARIAD (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Eisai (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst); Xcovery (Inst)
 
Julian R. Molina
No Relationships to Disclose
 
Geoffrey Liu
Honoraria - novartis; pfizer
Consulting or Advisory Role - AstraZeneca/MedImmune; novartis; pfizer; Roche Canada; takeda
Research Funding - roche (Inst)
 
Angelo Delmonte
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Novartis
 
Santiago Viteri Ramirez
Consulting or Advisory Role - Boehringer Ingelheim; Clovis Oncology; Idea Pharma; Novartis; Promega; Roche; Targovax
Research Funding - Abbvie; ARIAD; Astex Pharmaceuticals; AstraZeneca/MedImmune; Boehringer Ingelheim; Clovis Oncology; CytRx Corporation; Daiichi Sankyo; GlaxoSmithKline; Hanmi; Incyte; Merck KGaA; Novartis; Pfizer; Puma Biotechnology; Roche; Servier; VAXON Biotech
 
Alessandra Bearz
No Relationships to Disclose
 
Yvonne J. Summers
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Lilly; MSD; Pfizer; Tesaro
 
William Reichmann
No Relationships to Disclose
 
David Kerstein
Employment - ARIAD
Stock and Other Ownership Interests - ARIAD
 
Scott N. Gettinger
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb; Janssen
Research Funding - ARIAD; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Incyte; Pfizer; Roche/Genentech
 
Dong-Wan Kim
No Relationships to Disclose